|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn896850634 |
003 |
OCoLC |
005 |
20231120111913.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
141023s2014 ne a o 000 0 eng d |
040 |
|
|
|a UKMGB
|b eng
|e pn
|c UKMGB
|d OCLCO
|d N$T
|d UIU
|d YDXCP
|d OCLCF
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d U3W
|d D6H
|d WYU
|d OCLCA
|d MERER
|d OCLCQ
|d UX1
|d VT2
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCA
|d OCL
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
016 |
7 |
|
|a 016941144
|2 Uk
|
016 |
7 |
|
|a 016938660
|2 Uk
|
019 |
|
|
|a 897070319
|a 1066605664
|a 1235116096
|a 1235841235
|
020 |
|
|
|a 9780128005798
|q (electronic bk.)
|
020 |
|
|
|a 0128005793
|q (electronic bk.)
|
020 |
|
|
|z 9780128000939
|q (hbk.)
|
020 |
|
|
|z 0128000937
|
035 |
|
|
|a (OCoLC)896850634
|z (OCoLC)897070319
|z (OCoLC)1066605664
|z (OCoLC)1235116096
|z (OCoLC)1235841235
|
050 |
|
4 |
|a RA645.C34
|
060 |
0 |
0 |
|a 2015 E-235
|
060 |
1 |
0 |
|a WK 835
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.1
|2 23
|
245 |
0 |
0 |
|a Glucose intake and utilization in pre-diabetes and diabetes :
|b implications for cardiovascular disease /
|c edited by Ronald Ross Watson, Betsy Dokken.
|
264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2014.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
336 |
|
|
|a still image
|b sti
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a CIP data; item not viewed.
|
505 |
0 |
|
|a Front Cover; Glucose Intake and Utilization in Pre-Diabetes and Diabetes; Copyright Page; Dedication; Contents; List of Contributors; Preface; Part I: Pre-Diabetes in Health and Disease: Prevention and Treatment; Section 1: Modulation of Pre-Diabetes and Altered Glucose Metabolism: Pathophysiology, Drugs, Genetics, Epigenetics, and Nu ... ; Section 1A: Background on Pre-Diabetes and Its Management; Section 1B: Physiological Modulators of Pre-Diabetes and Cardiovascular Disease Development; Section 2: Nutrition and Food to Modulate Pre-Diabetes and Resulting Cardiac Disease.
|
505 |
8 |
|
|a Section 2A: Mechanisms of Pre-Diabetes and Diabetes Modulation of Cardiac TissuesSection 2B: Dietary Supplements in Prevention of Pre-Diabetes and Diabetes and Thus Related Cardiac Dysfunction; Part II: Diabetes; Section 3: Diabetes in Development and Pathology of Cardiovascular Disease; Section 3A: Role of Foods in Cardiovascular Problems Promoted by Diabetes; Section 3B: Exercise Diabetes and Cardiovascular Disease; Section 3C: Nutrition and Food to Modulate Diabetes: Heart and Vascular Health; About the Editors; Acknowledgments.
|
505 |
8 |
|
|a I. Pre-Diabetes in Health and Disease: Prevention and Treatment1 Modulation of Pre-Diabetes and Altered Glucose Metabolism: Pathophysiology, Drugs, Genetics, Epigenetics, and Nutrition; 1A Background on pre-diabetes and its management; 1 Early Origins of Health and Disease; Introduction; Developmental Programming of MS (CVD): Human Data; Excess Nutrients During Fetal Growth and Long-Term Consequences; Mechanisms Underlying Fetal Overgrowth; Effects of Maternal Gestational Weight Gain; Consequences of Being Large at Birth; Consequences of Exposure to Maternal Diabetes or Obesity In Utero.
|
505 |
8 |
|
|a Undernutrition During Pregnancy as a Cause of MS and CVDThe Consequences of Being Small at Birth; The Thrifty Phenotype Hypothesis; Maternal Caloric Restriction: the Dutch Famine; The Consequences of Preterm Birth; Effects of Postnatal Nutrition and Catch-Up Growth; Developmental Programming of MS (CVD): Animal Models; Nutritional Modifications; Proteins and Caloric Restriction; Carbohydrates; High-Fat Diet; Neonatal Overnutrition and Catch-Up Growth; Animal Models of Human Type 1 and 2 Diabetes; Animal Models of T1D; Surgical Models; Chemical Model; Spontaneous Animal Models; NOD Mouse.
|
505 |
8 |
|
|a BB RatAnimal Models of T2D; Production of Spontaneous Diabetic Rats; Chemical Model; Animal Model of Gestational Diabetes; Uteroplacental Insufficiency; Glucocorticoids Exposure; Mechanisms; Oxidative Stress; Epigenetic Regulation; DNA Methylation; Histone Modifications; Non-coding RNAs; Conclusion; References; 2 Diabetes and Obesity: The Impact of Their Coincidence on Health and Life; Introduction; Epidemiology; Pathophysiology; Metabolic Syndrome; Complications of Obesity and DM: Impact on Health and Life; Cardiovascular Complications; Renal Complications; Sexual Dysfunction; Osteoporosis.
|
520 |
|
|
|a This important reference, edited by Ronald Ross Watson and Betsy Dokken, collects the research needed to make the distinct connection between pre-diabetes, diabetes, and cardiovascular disease. Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease explains the mechanisms of progression from pre-diabetes to diabetes to cardiovascular disease. Since pre-diabetes and diabetes are important cardiovascular disease risk factors, and impaired glucose metabolism among cardiac patients is extremely prevalent, the importance of reviewing pre-diabetes and i.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Risk factors.
|
650 |
|
0 |
|a Diabetes
|x Complications.
|
650 |
|
0 |
|a Blood glucose.
|
650 |
|
0 |
|a Diabetes.
|
650 |
|
0 |
|a Diabetic angiopathies.
|
650 |
|
0 |
|a Metabolic syndrome.
|
650 |
|
0 |
|a Prediabetic state.
|
650 |
1 |
2 |
|a Diabetes Complications
|0 (DNLM)D048909
|
650 |
1 |
2 |
|a Glucose
|x metabolism
|0 (DNLM)D005947Q000378
|
650 |
2 |
2 |
|a Diabetes Mellitus
|0 (DNLM)D003920
|
650 |
2 |
2 |
|a Diabetic Angiopathies
|0 (DNLM)D003925
|
650 |
2 |
2 |
|a Metabolic Syndrome
|0 (DNLM)D024821
|
650 |
2 |
2 |
|a Prediabetic State
|0 (DNLM)D011236
|
650 |
|
2 |
|a Blood Glucose
|0 (DNLM)D001786
|
650 |
|
6 |
|a Appareil cardiovasculaire
|0 (CaQQLa)201-0057760
|x Maladies
|0 (CaQQLa)201-0057760
|x Facteurs de risque.
|0 (CaQQLa)201-0374823
|
650 |
|
6 |
|a Diab�ete
|x Complications et s�equelles.
|0 (CaQQLa)201-0019983
|
650 |
|
6 |
|a Glyc�emie.
|0 (CaQQLa)201-0018089
|
650 |
|
6 |
|a Diab�ete.
|0 (CaQQLa)201-0010252
|
650 |
|
6 |
|a Angiopathies diab�etiques.
|0 (CaQQLa)201-0033393
|
650 |
|
6 |
|a Syndrome m�etabolique.
|0 (CaQQLa)201-0423716
|
650 |
|
6 |
|a Pr�ediab�ete.
|0 (CaQQLa)201-0112356
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Prediabetic state
|2 fast
|0 (OCoLC)fst01075018
|
650 |
|
7 |
|a Metabolic syndrome
|2 fast
|0 (OCoLC)fst01738050
|
650 |
|
7 |
|a Diabetic angiopathies
|2 fast
|0 (OCoLC)fst00892225
|
650 |
|
7 |
|a Diabetes
|2 fast
|0 (OCoLC)fst00892147
|
650 |
|
7 |
|a Blood glucose
|2 fast
|0 (OCoLC)fst00834825
|
650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Risk factors
|2 fast
|0 (OCoLC)fst00847213
|
650 |
|
7 |
|a Diabetes
|x Complications
|2 fast
|0 (OCoLC)fst00892153
|
700 |
1 |
|
|a Watson, Ronald R.
|q (Ronald Ross),
|e editor.
|
700 |
1 |
|
|a Dokken, Betsy,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|z 9780128000939
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128000939
|z Texto completo
|